5 Ways This Tech Leader Is Crushing a $700 Billion Market

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Michael A. Robinson

This time, Wall Street didn't freak out.

In fact, the S&P 500 had its best day in eight sessions last Thursday as stocks across the board entered a rally.

You can chalk that up to the fact that just the day before the Federal

Reserve struck a very dovish tone, suggesting interest rates won't rise far or fast this year.

What didn't get much notice is just how volatile the bond market had become over the past six weeks.

Here's the thing. Choppy bond trades by definition means there's quite a frenzy of both buying and selling.

And that's great news for savvy tech investors.

Let me explain. Even on a "calm day," the nation's bond market is highly active. We're talking a daily volume of $700 billion, more than three times that for stocks.

And it's our mission to look for a tech angle into this massive segment that will give us market-crushing profits.

Today, I'm going to reveal a firm that is doing just that.

And I'll show you the five reasons why this is the single best way to play this massive market…

Check it out…

Where the Money's At

Please don't misunderstand me. I'm in no way suggesting you bypass big tech winners and other equities in favor of bonds, even if we see higher interest rates ahead.

It's just that many investors buy bonds or bond funds for the income, and give up a lot of growth. But as I always say – avoid false dichotomies. You want at least a portion of your "fixed income" portfolio to give you so-so growth.

Otherwise, inflation can eat up a lot of your paper profits. If we could just capture a fraction of the bond market's amazing volume, we stand to make a lot of money.

Now, the U.S. stock market boasts roughly 6,500 shares traded on major exchanges. Though that's quite a lot to choose from, it's only a fraction of the more than 200,000 types of unique taxable bonds offered.

Here's the thing. Despite the rise of the Web and electronic trading, most broker dealers still buy and sell directly with each other. Analyst say that electronic bond trading only accounts for a little more than 20% of all transactions.

As you can see, that's quite a fertile field for MarketAxess Holdings Inc. (Nasdaq:MKTX). This is the premier high-tech firm serving the bond market, and it's a company with a lot of room to grow.

For instance, the tech leader in this space right now handles 95% of all electronic bond deals. But that is still less than 20% of all bond trades made today.

To show you why this exciting stock still has plenty of upside ahead, let's run it through my five filters for building wealth with market-crushing tech winners.

Tech Wealth Builder Rule No. 1: Great Companies Have Great Operations

I'm talking about well-run firms with top-notch leaders.

And MarketAxess Holdings has a CEO/founder who is second to no one in the fixed income market. Richard M. McVey began his career at storied Wall Street firm JPMorgan Chase & Co. (NYSE:JPM).

Beginning in 1992, he spent four years serving as managing director and head of JP Morgan's North American futures and options business, and then served as head of North American fixed income sales and institutional client relations.

Concannon has a Master's degree in business, as well as a law degree. He's also had stints at Nasdaq, Instinet, and Cboe Global Markets, one of the world's largest exchange holding companies.

And just a few weeks ago, at MarketAxess, McVey moved to strengthen the senior team. He named Chris Concannon as president and chief operating officer.

Tech Wealth Builder Rule No. 2: Separate the Signal from the Noise

To create real wealth, you have to ignore the hype and find companies that have rock-solid fundamentals.

The firm has that in spades. It boasts a 49% operating market, and a 27% return on equity. This is a company with nearly $267 million in cash, and stockholder's equity is seven times greater than the firm's total liabilities.

Right now, Wall Street looks at the bond and stock markets as plain binary choices. The heard doesn't seem to grasp the major fundamental here. As the world goes digital, there's plenty of upside for a firm that is leading the way.

While Wall Street busies itself handicapping the Fed's actions, our team at MarketAxcess is getting ready for more trading volume. They recently added a module that lets clients use data analytics to improve their bond trades, and now count more than 1,500 active clients.

Join the conversation. Click here to jump to comments…

Michael A. Robinson

About the Author

Browse Michael's articles | View Michael's research services

Michael A. Robinson is one of the top financial analysts working today. His book "Overdrawn: The Bailout of American Savings" was a prescient look at the anatomy of the nation's S&L crisis, long before the word "bailout" became part of our daily lexicon. He's a Pulitzer Prize-nominated writer and reporter, lauded by the Columbia Journalism Review for his aggressive style. His 30-year track record as a leading tech analyst has garnered him rave reviews, too. Today he is the editor of the monthly tech investing newsletter Nova-X Report as well as Radical Technology Profits, where he covers truly radical technologies – ones that have the power to sweep across the globe and change the very fabric of our lives – and profit opportunities they give rise to. He also explores "what's next" in the tech investing world at Strategic Tech Investor.

… Read full bio

Ignore The "3-T's" - Try NetLease Real Estate ETF Instead

&l;p&g;With all due respect to anyone renting right now, dealing with tenants can be a giant pain in the neck.

Unless we&a;rsquo;re talking about a slumlord or some other kind of unethical real estate baron &a;ndash; and yes, I fully acknowledge those do exist &a;ndash; most landlords tend to work very hard for their income.

For starters, there&a;rsquo;s the normal, built-into-the-lease expectations they have to manage. This includes timely renovations and building upgrades, staying on top of the regular wear and tear of a building (aka depreciation), and taking care of the toilets, the trash and the taxes.

Those last three are known as the three Ts in this line of business (toilets, trash, and taxes).

Then there are &a;ldquo;those&a;rdquo; kinds of tenants they have to deal with. Tom Chiarella, who was a landlord for almost two decades, has some stories to tell in that regard. According to &l;a href=&q;https://www.popularmechanics.com/home/a25120/landlord/&q; target=&q;_blank&q;&g;his article on Popular Mechanics&l;/a&g;, the following details are some of the lesser problems he had to face over the course of his real estate career:

&l;/p&g;&l;blockquote&g;People will flush anything down a toilet. Curlers. Popsicle wrappers. Combs. I&s;m not saying they do it on purpose. Maybe they didn&s;t notice the jet-black comb on the blazingly contrasting white porcelain floor of the toilet bowl. Maybe they just flicked the handle and down it went. Accidents happen. But when you&s;re the one kneeling on a damp bath towel on a Wednesday afternoon, fishing around in a toilet with a thirty-foot snake, I&s;m telling you: You see some stuff. Poker chips. Warning labels. Handfuls of expired vitamins. There was an afternoon when I, the landlord, stood with a plumber as he ground around for about fifteen minutes until he broke through the offending blockage. Moments later, an artichoke leaf floated up, then another, and another. Seriously: artichoke leaves. &q;I don&s;t know anything about that,&q; my tenant told me when I called that night. Paradoxically, he then added, &q;That must have been an accident.&q;&l;/blockquote&g;

For the record, artichokes aren&a;rsquo;t exactly the smallest vegetable available. They&a;rsquo;re much better disposed of in a trash can or compost bin.

&l;strong&g;The Obvious Upside to the Job&l;/strong&g;

Admittedly, those kinds of aggravations can be more on the residential-specific side of the landlord spectrum. However, there are plenty of businesses that are more than capable of creating undesirable, unnecessary &a;ldquo;situations&a;rdquo; in their own special ways.

All things considered, if you&a;rsquo;ve never been a landlord before, you might want to count your blessings.

With that said, there is obviously money to be made out of it. Otherwise, nobody in a free society would ever willingly subject themselves to those kinds of reoccurring headaches and hassles.

When managed with the right goals and the right application, renting out property can bring in the kind of money that can build real estate empires &a;ndash; the very concept that REITs are built on.

People need homes, and businesses need space. Yet not all of them &a;ndash; maybe even most of them &a;ndash; aren&a;rsquo;t always willing or able to buy up their own property in the process. So they rent instead, a decision that provides steady income for hundreds of publicly traded REITs&a;hellip; and reliable dividend returns for investors like you and me&a;hellip;

When everything goes as planned.

While there&a;rsquo;s no way to predict absolutely everything, there is a way REITs can significantly shorten the list of negative possibilities they have to worry about. That&a;rsquo;s through triple net leases.

&l;strong&g;The New Big Deal on the REIT Block&l;/strong&g;

I&a;rsquo;ve long-since noted that, out of all the REITs I cover, the ones that operate with triple net leases are among my favorites (I also have

built over 100 free-standing buildings myself, as a developer). From a landlord&a;rsquo;s perspective, these are about the most favorable leasing conditions around.

Here&a;rsquo;s how I described them in an April 2018 &l;em&g;Forbes &l;/em&g;piece titled, &a;ldquo;3 Highly Predictable REITs to Help You Sleep Well at Night.&a;rdquo; These are rental properties &a;ldquo;with long-term leases (10-25 years)&a;rdquo; signed by &a;ldquo;high credit-quality tenants.&a;rdquo;

They&a;rsquo;re called net leases because:

&l;blockquote&g;&a;ldquo;&a;hellip; they generally use a triple-net lease structure, whereby tenants pay all expenses related to property management: property taxes, insurance, and maintenance. &l;a href=&q;https://twitter.com/intent/tweet?url=http%3A%2F%2Fwww.forbes.com%2Fsites%2Fbradthomas%2F2018%2F04%2F09%2F3-highly-predictable-reits-to-help-you-sleep-well-at-night%2F&a;amp;text=Like%20a%20ground%20lease%2C%20triple-net%20leases%20result%20in%20long-term%2C%20relatively%20predictable%20income%20streams.&q; target=&q;_blank&q;&g;Like a ground lease, triple-net leases result in long-term, relatively predictable income streams.&l;/a&g; Similar to a bank, net lease REITs essentially capture the &a;ldquo;spread&a;rdquo; between the acquisition cap rate and their cost of capital. Furthermore, compared to other REITs, net lease REITs function more like a financing company rather than an operating company. These REITs hold the long-term, capital-intensive real estate assets that other companies prefer not to hold on their balance sheets.&a;rdquo;&l;/blockquote&g;

In and of itself, that&a;rsquo;s a fine kind of business structure to bet on. But perhaps better still is how, as of today, there is now officially an ETF on the market that holds absolutely nothing other than triple net REITs.

I&a;rsquo;m extremely excited to tell you all about it&a;hellip;

&l;strong&g;This New REIT Has Elements of the SWAN Elements&l;/strong&g;

Today NetLease Corporate Real Estate ETF (NETL) is launching and the strategy for this fund is that it is the first ETF focused solely on Net Lease REITs, which is one of the fastest growing sectors within the REIT space. Just a few days ago I &l;a href=&q;https://seekingalpha.com/article/4249377-march-madness-nothing-net-lease-reits&q; target=&q;_blank&q;&g;wrote an article&l;/a&g; explaining,

&l;blockquote&g;&a;ldquo;the backdrop (low rates, slightly higher yields, acquisition abundance) remains favorable for Triple Net REIT transaction volumes and earnings given their cost and access to capital advantage.&a;rdquo;&l;/blockquote&g;

NETL is a pure-play Net Lease REIT ETF that encompasses a variety of REITs that provide sustainable cash flows by leasing their properties through long-term contractual leases on a triple-net lease basis. The leases have terms that are generally 10 years or longer, predetermined rental rate increases, and minimal landlord responsibilities.

This newly created Net Lease ETF is based on the Fundamental Income Net Lease Real Estate Index (NNNLSCTR) which is calculated by Nasdaq and aims to allow investors to benefit from these unique Net Lease REIT fundamentals. The NETLease ETF does not have exposure to multi-tenant malls, traditional office buildings and multifamily owners, all of whom have significant capital expenditures and operating expense obligations.

&a;ldquo;We are thrilled to be working with the Fundamental Income team to bring this timely and innovative fund to market,&a;rdquo; said J. Garrett Stevens, CEO of Exchange Traded Concepts. &a;ldquo;This Fund tracks the Net Lease real estate sector, which exemplifies consistent and predictable cash flows that Net Lease REITs derive from a diverse portfolio of corporate-leased properties. Great colleagues and great ideas are the true drivers of ETF success,&a;rdquo; continued Stevens. &a;ldquo;We&a;rsquo;re very pleased to add Fundamental Income and NETL to our growing list of affiliates and innovative ETF solutions.&a;rdquo; Chris Burbach, co-founder and Partner of Fundamental Income stated,

&l;blockquote&g;&a;ldquo;We started Fundamental Income with a simple view that investments with cash flows built upon identifiable underlying fundamentals, that are stable and predictable, should be worth more than those without a clear foundation or less certainty. Net Lease REITs have the potential to provide investment income and capital preservation, in a market searching for both, which is why we are excited to partner with ETC. We believe this ETF offers investors broad exposure to the tangible U.S. economy through the underlying predictable rents of NETL. The time has come for investors to shift their focus from property appearances to results and for Net Lease real estate to stand on its own &a;ndash; we created the Index to do just that.&a;rdquo;&l;/blockquote&g;

Burbach and co-founder Alexi Panagiokapoulos know the Net Lease REIT sector well as they formerly were employed with Store Capital (STOR) &a;ndash; Burbach was Executive VP of Underwriting and Panagiokapoulos specialized in credit and underwriting.

The new REIT ETF should create plenty of buzz as the portfolio of 24 REITs generates very stable revenues supported by over 23,000+ individual stand-alone properties. The ETF has no more than 3.5% exposure to any one tenant and no more than 20% exposure to any one tenant industry and no more than 5% exposure to any one state in the US (except Texas, which is the outlier at roughly 10%). The fee structure is 60 bps.

KaChing, KaChing&a;hellip;

That means, forget about the frig&a;rsquo;n 3 T&a;rsquo;s, just let NetLease ETF do all of the dirty work.

This new strategy is well thought-out, and I really like the fact that there is tremendous diversification across property sectors (24 REITs in the portfolio). It will be interesting to track this ETF, especially since we also recently created our own Net Lease REIT Index called &l;strong&g;SWANO&l;/strong&g;.

The participants include Store Capital, W.P. Carey (WPC), Agree Realty (ADC), National Retail Properties (NNN), and Realty Income (O). As most know, we also created an equity REIT Index called &l;strong&g;DAVOS&l;/strong&g;.

The participants include Digital Realty (DLR), American Tower (AMT), Ventas, Inc. (VTR), Realty Income (O), and Simon Properties.

In a few weeks (hopefully two) we plan to launch our new website and included in the iREIT Research Lab we will provide real-time results for over 30 REIT ETFs (including NetLease ETF), REIT Benchmarks, and our proprietary tracking indexes such as SWANO, DAVOS, and BLAST (our commercial mortgage REIT Index).

In closing: When it comes to Net Lease investing, there&a;rsquo;s really no need to be a market timer. I have made the argument for years and years on Seeking Alpha, there&a;rsquo;s one simple rule to remember when it comes to Net Lease REITs (Realty Income&a;rsquo;s former CEO, Tom Lewis, taught me this rule): &l;strong&g;5 + 5 = 10&l;/strong&g;

What this means is that when you decide to purchase shares in a Net Lease REIT, there&a;rsquo;s no reason to &a;ldquo;get too cute&a;rdquo;. You are typically going to obtain a dividend yield of approximately 5% (I know, blue chips like O are yielding much less now) and growth of another 5% (on average), and the result is an expected total return of 10%.

That&a;rsquo;s much easier than pulling artichokes out of the toilet, right?

The author does not own shares in NETL, but he does own shares in DLR, VTR, O, SPG, BXMT, LADR, STWD, TRTX, STOR, and WPC.

&a;nbsp;

&a;nbsp;

&a;nbsp;

&a;nbsp;

Investors shouldn't get scared by latest market pullback: Federated

One of Wall Street's biggest bulls suggests the latest market pullback is no fluke.

Federated Investors' Phil Orlando believes the 2019 rally is increasingly vulnerable to a setback that could reach into the second quarter. Yet, he contends it's no reason for investors to hunker down.

"You're up about 20 percent from Christmas Eve's bottom. We're probably due for some consolidation," the firm's chief equity strategist said Thursday on CNBC's "Futures Now."

That forecast appeared to be taking shape on Friday when the Dow fell 460 points 1.77 percent, and the S&P 500 posted its worst day since January 3.

According to Refinitiv Tradeweb data, the spread between the 3-month Treasury bill and the 10-year note rate turned negative — albeit temporarily — for the first time since 2007. The move sparked recession jitters while weaker than expected overseas data fed into global growth worries.

However, Orlando told "Futures Now" on Friday he doubts these are the catalysts that'll carry the sell-off.

He cites ongoing U.S.-China trade negotiations and the first quarter earnings reports, which could turn negative on a year-over-year basis, as the longer-term potential drivers for a pullback.

"In a worst case scenario... we move back into that 2600 neighborhood depending on how bad the earnings are, and how slopping the guidance is," he said. "I don't think it's going to be a disaster. I don't think we're going to retest the Christmas Eve bottoms."

Orlando, who has $460 billion in assets under management, has a 3100 year-end price target on the S&P 500 — an 11 percent gain from current levels. According to Orlando, the more typical scenario is the S&P tests the old 2800 resistance level, and then regains its footing. The S&P closed at 2800.71 on Friday.

'Use any weakness as a buying opportunity'

"We're feeling very comfortable that the back three quarters of the year are going to show improvement over the first quarter," he added.

Orlando is building his bullish case on economic and market data, and that's been working this year. In early January on "Futures Now," he predicted the record rally would wipe out correction losses, and called long-time bears "shameless."

Now, he's telling investors not to be scared of pullbacks.

"We would use any weakness as a buying opportunity," said Orlando, who's particularly bullish on large cap domestic value and small cap stocks.

Disclaimer

The FBI is reportedly aiding criminal probe of Boeing 737 Max certification

Shares of Boeing fell in after-market trading Wednesday on news that the FBI has reportedly joined in a criminal investigation of the certification process for the company's 737 Max jets, two of which have crashed since October killing 346 people.

The Seattle Times reported that the agency is assisting federal aviation investigators in a federal grand jury probe based in Washington, D.C. looking into the process. Boeing's shares were down less than 1 percent.

The news comes after the Department of Transportation on Tuesday asked the agency's watchdog to audit the Federal Aviation Administration's approval of Boeing's 737 Max 8 aircraft.

Transportation Secretary Elaine Chao on Tuesday sent a memo to Calvin Scovel, the department's inspector general, formalizing the request.

Boeing and the FAA, which certified the plane two years ago, are under increasing scrutiny after the crash of Ethiopian Airlines Flight 302 on March 10, which went down shortly after takeoff, killing all 157 people on board. Investigators who have extracted data from the airliner's black boxes said they detected "clear similarities" between the Ethiopian Airlines flight and a crash in Indonesia in October that killed all 189 on board.

The FAA said Wednesday that reviewing a possible software fix for the grounded airplanes is "an agency priority."

Boeing has been working on a software update that is expected to correct issues with the 737 Max maneuvering characteristics augmentation system. That system, which can push the nose of a 737 Max lower to avoid a stall, is suspected as being a contributing factor in the crash of a Lion Air jet last October.

Hot Heal Care Stocks To Watch Right Now

tags:CVCO,BWFG,DNN,UNP,DEST,BLK,

The Walt Disney Co. (NYSE: DIS) reported fiscal first-quarter 2017 results after markets closed Tuesday afternoon. The entertainment giant posted quarterly adjusted EPS of $1.55 and $14.78 billion in revenues. In the same period a year ago, the company reported EPS of $1.63 on revenues of $15.24 billion. First-quarter results compare to the Thomson Reuters consensus estimates for EPS of $1.50 and $15.26 billion in revenues.

Cable networks revenue dropped 2% and broadcasting networks revenues were flat. Total media networks revenue fell 2% from $6.33 billion to $6.23 billion. Operating income fell 4% from $1.41 billion to $1.36 billion. The drop in media networks operating income was due to higher programming costs at ESPN, among other things.

Broadcasting revenues were flat buy operating income rose 28% to $379 million. The increase was attributed to revenue growth resulting from rate increases while impressions were down due to “lower average viewership” and, “to a lesser extent, fewer units delivered.”

Hot Heal Care Stocks To Watch Right Now: Cavco Industries, Inc.(CVCO)

Advisors' Opinion:

• [By Lisa Levin] Gainers Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study. Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing. ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating. Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook. TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy. Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday. Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital. Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00. SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday. Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40. Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance. Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins. Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr
• [By Lisa Levin] Gainers Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing. Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study. Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook. Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital. TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy. Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance. ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating. Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011. InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS. Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy.. SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday. Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
• [By Motley Fool Transcribers]

  Cavco Industries Inc  (NASDAQ:CVCO)Q3 2019 Earnings Conference CallFeb. 05, 2019, 8:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Max Byerly]

  Cavco Industries (NASDAQ:CVCO) was upgraded by analysts at BidaskClub from a hold rating to a buy rating.

Hot Heal Care Stocks To Watch Right Now: Bankwell Financial Group, Inc.(BWFG)

Advisors' Opinion:

• [By Logan Wallace]

  Here are some of the media headlines that may have effected Accern Sentiment Analysis’s analysis:

  Get Bankwell Financial Group alerts: Should Income Investors Buy Bankwell Financial Group Inc (NASDAQ:BWFG) Before Its Ex-Dividend? (finance.yahoo.com) Zacks: Analysts Expect Bankwell Financial Group Inc (BWFG) Will Post Quarterly Sales of $15.20 Million (americanbankingnews.com) Bankwell Financial Group Inc (BWFG) Expected to Post Earnings of $0.61 Per Share (americanbankingnews.com) Garnett joins Bankwell Financial Group Board of Directors (darientimes.com)

  NASDAQ:BWFG traded up $0.08 on Thursday, reaching $31.46. 5,600 shares of the company’s stock were exchanged, compared to its average volume of 10,861. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.32. The firm has a market capitalization of $247.99 million, a PE ratio of 15.50 and a beta of 0.44. Bankwell Financial Group has a 52 week low of $30.11 and a 52 week high of $37.95.

• [By Shane Hupp]

  Bankwell Financial Group Inc (NASDAQ:BWFG) EVP Laura Waitz sold 1,265 shares of the company’s stock in a transaction on Friday, September 7th. The shares were sold at an average price of $31.30, for a total value of $39,594.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

• [By Logan Wallace]

  Research analysts at Boenning Scattergood started coverage on shares of Bankwell Financial Group (NASDAQ:BWFG) in a report issued on Thursday, The Fly reports. The firm set an “outperform” rating on the bank’s stock.

Hot Heal Care Stocks To Watch Right Now: Denison Mine Corp(DNN)

Advisors' Opinion:

• [By Steve Symington, Reuben Gregg Brewer, and Sean Williams]

  We asked three top Motley Fool contributors to weigh in to that end. Read on to learn why they like JD.com (NASDAQ:JD), OrganiGram (NASDAQOTH:OGRMF), and Denison Mines (NYSEMKT:DNN).

• [By Shane Hupp]

  Denison Mines (TSE:DML) (NYSE:DNN) had its price objective hoisted by Cormark from C$1.60 to C$1.80 in a research report sent to investors on Wednesday morning.

• [By Logan Wallace]

  Denison Mines (TSE:DML) (NYSE:DNN) had its price target upped by Raymond James from C$0.95 to C$1.25 in a research note issued to investors on Wednesday. Raymond James currently has a market perform rating on the stock.

• [By Jim Robertson]

  Last Thursday, small cap uranium mining stock Denison Mines Corp (NYSEAMERICAN: DNN), which is also focused on the Athabasca Basin of Saskatchewan, reported 2017 earnings and gave its outlook for 2018 with the outlook coming with extensive commentary about the uranium market and Athabasca. David Cates, the President and CEO of Denison Mines Corp, gave the following commentary:

• [By Scott Levine]

  Shares of Denison Mines (NYSEMKT:DNN), a uranium exploration and development company, climbed 28% in September, according to data from S&P Global Market Intelligence. In addition to the news that Denison intends to acquire 100% of Cameco's interest in the Wheeler River Joint Venture, shareholders celebrated the reporting of favorable results from the company's pre-feasibility study (PFS) conducted at Wheeler River. 

Hot Heal Care Stocks To Watch Right Now: Union Pacific Corporation(UNP)

Advisors' Opinion:

• [By Joseph Griffin]

  Gemmer Asset Management LLC increased its stake in shares of Union Pacific Co. (NYSE:UNP) by 200.0% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 1,950 shares of the railroad operator’s stock after acquiring an additional 1,300 shares during the period. Gemmer Asset Management LLC’s holdings in Union Pacific were worth $318,000 at the end of the most recent reporting period.

• [By Ethan Ryder]

  Here are some of the media stories that may have effected Accern’s analysis:

  Get Union Pacific alerts: Union Pacific (UNP) Price Target Raised to $155.00 at Robert W. Baird (americanbankingnews.com) Seaport Global Securities Comments on Union Pacific Co.’s FY2019 Earnings (UNP) (americanbankingnews.com) Union Pacific Co. (UNP) Expected to Announce Quarterly Sales of $5.54 Billion (americanbankingnews.com) Zacks: Brokerages Anticipate Union Pacific Co. (UNP) Will Post Earnings of $1.88 Per Share (americanbankingnews.com) Jobs report shows we have 'perfect economy' for stocks (finance.yahoo.com)

  A number of equities research analysts recently issued reports on the company. Morgan Stanley lifted their target price on Union Pacific from $125.00 to $136.00 and gave the company an “equal weight” rating in a research report on Friday. Cowen reissued a “market perform” rating and issued a $153.00 target price (up previously from $140.00) on shares of Union Pacific in a research report on Friday. Robert W. Baird lifted their target price on Union Pacific from $144.00 to $155.00 and gave the company a “neutral” rating in a research report on Monday. TD Securities dropped their target price on Union Pacific from $155.00 to $150.00 and set a “buy” rating on the stock in a research report on Friday, April 27th. Finally, Loop Capital lifted their target price on Union Pacific to $153.00 and gave the company a “hold” rating in a research report on Friday. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and twelve have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $146.70.

• [By Matthew DiLallo]

  Union Pacific (NYSE:UNP) is one of the companies working to capture this opportunity to ship oil out of the Basin. The railroad operator noted on its second-quarter call that it had some capacity to move Permian crude and should see results in the third and fourth quarters. Union Pacific has since signed a deal with a logistics company to ship 400,000 barrels of crude per month through the next year, which lines up with when new pipelines should enter service, though that agreement could last into 2020 if needed. More deals could follow as other producers seek ways to gain greater market access for Permian oil. 

• [By Matthew DiLallo]

  Railroads have also been working to fill in the gaps. Union Pacific (NYSE:UNP) signed a deal last year to ship to 400,000 barrels per month through the end of this year to help move crude out of the Permian until new pipelines start service. That decision paid off during the fourth quarter, when Union Pacific's crude oil shipments increased 25% as it helped producers get their oil to higher-priced refining and export markets.

• [By Shane Hupp]

  Financial Advocates Investment Management raised its position in Union Pacific Co. (NYSE:UNP) by 52.5% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,658 shares of the railroad operator’s stock after acquiring an additional 3,323 shares during the quarter. Financial Advocates Investment Management’s holdings in Union Pacific were worth $1,299,000 as of its most recent SEC filing.

Hot Heal Care Stocks To Watch Right Now: Destination Maternity Corporation(DEST)

Advisors' Opinion:

• [By Logan Wallace]

  Cato (NYSE: CATO) and Destination Maternity (NASDAQ:DEST) are both small-cap retail/wholesale companies, but which is the better stock? We will contrast the two companies based on the strength of their risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations.

• [By Alexander Bird]

  Here are last week's top-performing penny stocks:

  Penny Stock Current Share Price Last Week's Gain  Ambow Education Holdings Ltd. (NYSE: AMBO) $5.70 77.11% Nano Dimension (Nasdaq: NNDM) $2.61 75.11% Destination Maternity Corp. (Nasdaq: DEST) $5.79 71.84% CLPS Inc. (Nasdaq: CLPS) $9.72 71.15% NII Holdings Inc. (Nasdaq: NIHD) $3.20 56.33% Viveve Medical Inc. (Nasdaq: VIVE) $3.78 51.98% Galectin Therapeutics Inc. (Nasdaq: GALT) $9.18 41.82% Apricus Biosciences Inc. (Nasdaq: APRI) $0.36 34.70% Polymet Mining Corp. (NYSE: PLM) $1.01 31.13% Xenon Pharmaceuticals Inc. (Nasdaq: XENE) $8.20 28.46%

  Many investors struggle with finding stocks with this sort of breakout potential because they don't know where to look.

• [By Lisa Levin] Gainers Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares surged 115.8 percent to $4.3591. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity. Stellar Biotechnologies, Inc. (NASDAQ: SBOT) jumped 38.2 percent to $3.0251 after the company disclosed that it achieved robust viral clearance for its manufacturing process. Universal Corporation (NYSE: UVV) surged 26.7 percent to $61.40 after reporting fiscal Q4 results. Hudson Technologies Inc. (NASDAQ: HDSN) rose 18.9 percent to $2.58. Evolus, Inc. (NASDAQ: EOLS) shares gained 17.8 percent to $22.8009. The Cato Corporation (NYSE: CATO) shares gained 17.5 percent to $21.07 after the company posted better-than-expected first-quarter results. Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.9 percent to $3.3613. Destination Maternity Corporation (NASDAQ: DEST) shares gained 15.5 percent to $3.35 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan. AXT, Inc. (NASDAQ: AXTI) rose 15 percent to $7.65. nLIGHT, Inc. (NASDAQ: LASR) gained 14.5 percent to $34.27 following Q1 results. Achieve Life Sciences, Inc. (NASDAQ: ACHV) rose 14.3 percent to $11.4303. Bilibili Inc.. (NASDAQ: BILI) shares climbed 13.9 percent to $14.16 after announcing Q1 results. Babcock & Wilcox Enterprises, Inc. (NYSE: BW) gained 13.2 percent to $2.91 after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake. HUYA Inc. (NYSE: HUYA) gained 13.1

Hot Heal Care Stocks To Watch Right Now: BlackRock, Inc.(BLK)

Advisors' Opinion:

• [By Chris Lange]

  BlackRock Inc. (NYSE: BLK) will report its most recent quarterly results on Thursday. The consensus estimates call for $6.41 in EPS and $3.34 billion in revenue. Shares were last seen trading at $519.92, in a 52-week range of $375.52 to $594.52. The consensus price target is $615.85.

• [By Matthew DiLallo]

  The deal with KKR is the second private-equity-funded transaction NextEra Energy Partners has made in the last year. In September the company reached a unique financing agreement with leading asset manager BlackRock (NYSE:BLK) to fund a similar dropdown acquisition from NextEra. In that deal, NextEra Energy Partners paid $1.275 billion for 12 renewable-energy-generating facilities, which it partially financed with $750 million of convertible equity funding from BlackRock. The latest deal with KKR is on slightly better terms than the BlackRock agreement, as it features lower cash costs and the ability to issue equity to buy out the financing over a longer period, which increases NextEra Energy Partners' flexibility.

• [By Matthew DiLallo]

  NextEra Energy Partners (NYSE:NEP) announced this week that it would acquire a portfolio of wind and solar assets from its parent NextEra Energy (NYSE:NEE) for $1.275 billion. The transaction, which the company will finance through a unique arrangement with leading asset manager BlackRock (NYSE:BLK), keeps it on track to grow its 3.6%-yielding dividend at a 12% to 15% annual pace all the way through 2023. That forecast could energize the company to produce market-smashing returns in the coming years.

Top 5 Stocks For 2019

tags:EBMT,PGTI,KTEC,VLRS,SBGI,

D.B. Root & Company LLC purchased a new stake in Zayo Group Holdings (NYSE:ZAYO) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 15,725 shares of the technology company’s stock, valued at approximately $537,000.

Several other large investors have also recently made changes to their positions in ZAYO. Cerebellum GP LLC acquired a new position in shares of Zayo Group during the fourth quarter valued at approximately $126,000. SG Americas Securities LLC acquired a new position in shares of Zayo Group during the fourth quarter valued at approximately $141,000. American International Group Inc. acquired a new position in shares of Zayo Group during the fourth quarter valued at approximately $162,000. Thompson Davis & CO. Inc. increased its stake in shares of Zayo Group by 60.0% during the first quarter. Thompson Davis & CO. Inc. now owns 5,000 shares of the technology company’s stock valued at $171,000 after acquiring an additional 1,875 shares during the period. Finally, OLD Mutual Customised Solutions Proprietary Ltd. increased its stake in shares of Zayo Group by 102.8% during the fourth quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 7,300 shares of the technology company’s stock valued at $269,000 after acquiring an additional 3,700 shares during the period. Institutional investors own 87.19% of the company’s stock.

Top 5 Stocks For 2019: Eagle Bancorp Montana, Inc.(EBMT)

Advisors' Opinion:

• [By Max Byerly]

  Get a free copy of the Zacks research report on Eagle Bancorp Montana (EBMT)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  News coverage about Eagle Bancorp Montana (NASDAQ:EBMT) has trended somewhat positive on Saturday, according to Accern Sentiment. The research firm identifies positive and negative news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Eagle Bancorp Montana earned a news sentiment score of 0.07 on Accern’s scale. Accern also gave news articles about the bank an impact score of 45.1226009264191 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

• [By Max Byerly]

  Get a free copy of the Zacks research report on Eagle Bancorp Montana (EBMT)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  Get a free copy of the Zacks research report on Eagle Bancorp Montana (EBMT)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Eagle Bancorp Montana (EBMT)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Shane Hupp]

  BSB Bancorp (NASDAQ: EBMT) and Eagle Bancorp Montana (NASDAQ:EBMT) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, risk, dividends and earnings.

Top 5 Stocks For 2019: PGT, Inc.(PGTI)

Advisors' Opinion:

• [By Shane Hupp]

  Griffon (NYSE:GFF) and PGT Innovations (NYSE:PGTI) are both small-cap multi-sector conglomerates companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.

• [By Shane Hupp]

  Get a free copy of the Zacks research report on PGT Industries (PGTI)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on PGT Innovations (PGTI)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Ethan Ryder]

  Laurion Capital Management LP lessened its stake in PGT Innovations Inc (NYSE:PGTI) by 52.6% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 40,603 shares of the construction company’s stock after selling 45,000 shares during the quarter. Laurion Capital Management LP owned 0.08% of PGT Innovations worth $847,000 at the end of the most recent reporting period.

• [By Shane Hupp]

  News coverage about PGT Industries (NYSE:PGTI) has trended somewhat positive recently, Accern reports. Accern scores the sentiment of media coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. PGT Industries earned a media sentiment score of 0.10 on Accern’s scale. Accern also gave news stories about the construction company an impact score of 45.4754593412205 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Top 5 Stocks For 2019: Key Technology Inc.(KTEC)

Advisors' Opinion:

• [By Ethan Ryder]

  Press coverage about Key Technology (NASDAQ:KTEC) has been trending somewhat positive on Monday, according to Accern Sentiment. The research firm identifies positive and negative media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Key Technology earned a coverage optimism score of 0.11 on Accern’s scale. Accern also gave news coverage about the industrial products company an impact score of 47.5851902672258 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Top 5 Stocks For 2019: Controladora Vuela Compania de Aviacion, S.A.B. de C.V.(VLRS)

Advisors' Opinion:

• [By Adam Levine-Weinberg]

  In late 2016 and early 2017, profitability deteriorated rapidly at Mexican budget airline Volaris (NYSE:VLRS) due to market disruptions caused by the U.S. presidential election. Fears about a crackdown on trade or immigration under President Trump led to a sharp drop in the Mexican peso and a downturn in travel demand. However, Volaris seemed to be on the mend by this time last year, and its stock price rebounded to more than $15 last July.

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Controladora Vuela Co Avcn SA CV (VLRS)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Stephan Byrd]

  Goldman Sachs Group upgraded shares of Controladora Vuela Co Avcn SA CV (NYSE:VLRS) from a sell rating to a buy rating in a report issued on Tuesday, Marketbeat Ratings reports.

• [By Travis Hoium]

  Shares of Mexican airline Controladora Vuela Co Avcn SA CV (NYSE:VLRS) plunged as much as 20.3% in trading Monday after announcing earnings that led to fears of growing competition. At 12:25 p.m. EDT shares were still down 16.6% on the day. 

Top 5 Stocks For 2019: Sinclair Broadcast Group, Inc.(SBGI)

Advisors' Opinion:

• [By Steve Symington]

  Tribune Media stock plunged 16.7% in the wake of FCC chairman Ajit Pai stating he has "serious concerns" about Sinclair Broadcasting's (NASDAQ:SBGI) pending $3.9 billion acquisition of the television and digital media conglomerate. Sinclair shares also fell 11.7% on the news.

• [By Joseph Griffin]

  Entravision Communication (NYSE: EVC) and Sinclair Broadcast Group (NASDAQ:SBGI) are both consumer discretionary companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings and valuation.

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on Sinclair Broadcast Group (SBGI)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  Get a free copy of the Zacks research report on Sinclair Broadcast Group (SBGI)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  Virginia Retirement Systems ET AL lessened its stake in Sinclair Broadcast Group Inc (NASDAQ:SBGI) by 41.4% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 40,700 shares of the company’s stock after selling 28,700 shares during the period. Virginia Retirement Systems ET AL’s holdings in Sinclair Broadcast Group were worth $1,309,000 at the end of the most recent quarter.

• [By Travis Hoium]

  Twitter Inc (NYSE:TWTR), Scientific Games Corp (NASDAQ:SGMS), and Sinclair Broadcast Group Inc (NASDAQ:SBGI) don't have a lot in common from a business perspective, but all three have plunged over the past month. 

Top 10 Safest Stocks To Buy For 2019

tags:MODN,EURN,AXGN,UBSH,FELE,BEP,GLRE,OSK,REI,GSB,

Retail is in trouble. With the ease of shopping on Amazon, endless choices available online, and the industry's failure to keep up with the times, brick-and-mortar retail operations have been crushed. True tales of struggling chains, plunging stock prices and even bankruptcy have become commonplace in the once thriving retail sector.

---Recommended Link--- The SAFEST Way To Make Triple-Digit Gains In Blue-Chip Stocks...
Forget options and penny stocks. The market's BIGGEST profits come from its safest investments - you just have to know where to look. Find out how to cash in HERE.

However, within this chaos and wealth destructions lies the opportunity.

A few retailers are stepping up to the plate by revamping and providing today's consumers what they demand. By doing so, the sinking ships are righted, ushering in the new era of retail.

One way I like to identify investment opportunities is by boots-on-the-ground observation. Looking for investment opportunities has become so ingrained that it is second nature. In other words, I do it without even thinking about it and do it all the time, even on vacation!

The first firsthand observation is how I noticed this rare winning retailer.

Top 10 Safest Stocks To Buy For 2019: Model N, Inc.(MODN)

Advisors' Opinion:

• [By Max Byerly]

  Get a free copy of the Zacks research report on Model N (MODN)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Model N (MODN)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  Model N (NYSE: MODN) and Trade Desk (NASDAQ:TTD) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk and valuation.

• [By ]

  Finally, there's Model N (NYSE: MODN). My long-time readers might remember this revenue management cloud company for the life sciences and technology businesses: we sold its shares a year ago almost to the day, for a gain of 30% in about six months. I like MODN's business, and with long-term projected growth of 44%, now might be the time to revisit the shares. If you're a subscriber to Game-Changing Stocks, stay tuned...

• [By ]

  Finally, there's Model N (NYSE: MODN). My long-time readers might remember this revenue management cloud company for the life sciences and technology businesses: we sold its shares a year ago almost to the day, for a gain of 30% in about six months. I like MODN's business, and with long-term projected growth of 44%, now might be the time to revisit the shares. If you're a subscriber to Game-Changing Stocks, stay tuned...

• [By Motley Fool Transcribers]

  Model N Inc  (NYSE:MODN)Q1 2019 Earnings Conference CallFeb. 05, 2019, 5:00 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

Top 10 Safest Stocks To Buy For 2019: Euronav NV(EURN)

Advisors' Opinion:

• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers Teradyne, Inc. (NYSE: TER) fell 10.8 percent to $37.02 in pre-market trading after the company issued downbeat Q2 guidance. Edwards Lifesciences Corporation (NYSE: EW) fell 9.2 percent to $122.29 in pre-market trading. Edwards Lifesciences reported better-than-expected results for its first quarter, but issued weak earnings guidance for the second quarter. New Gold Inc. (NYSE: NGD) fell 8.8 percent to $2.30 in pre-market trading after rising 4.13 percent on Tuesday. Gold Fields Limited (ADR) (NYSE: GFI) fell 8.6 percent to $3.61 in pre-market trading. Natus Medical Incorporated (NASDAQ: BABY) fell 8.2 percent to $32.95 in pre-market trading after the company issued weak forecast for the second quarter. Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 7.9 percent to $3.50 in pre-market trading after climbing 27.09 percent on Tuesday. Bright Scholar Education Holdings Limited (NYSE: BEDU) shares fell 6.7 percent to $13.58 in pre-market trading after reporting Q1 results. Sangamo Therapeutics Inc (NASDAQ: SGMO) fell 5.9 percent to $16.75 in pre-market trading following announcement of a $200 million common stock offering. Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) shares fell 5.7 percent to $3.29 in pre-market trading after declining 3.32 percent on Tuesday. Euronav NV (NYSE: EURN) fell 4.8 percent to $8.40 in pre-market trading. Limelight Networks, Inc. (NASDAQ: LLNW) shares fell 4.3 percent to $4.69 in pre-market trading. Gaming and Leisure Properties Inc (NASDAQ: GLPI) shares fell 4.1 percent to $32.92 in pre-market trading after the company issued downbeat quarterly results and reported the retirement of CFO William Clifford
• [By Logan Wallace]

  Seanergy Maritime (NASDAQ: SHIP) and Euronav (NYSE:EURN) are both small-cap transportation companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

• [By Stephan Byrd]

  Euronav (NYSE:EURN) and TOP SHIPS (NASDAQ:TOPS) are both small-cap transportation companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.

Top 10 Safest Stocks To Buy For 2019: AxoGen, Inc.(AXGN)

Advisors' Opinion:

• [By Joseph Griffin]

  AxoGen (NASDAQ:AXGN) was upgraded by equities researchers at BidaskClub from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday.

• [By Motley Fool Transcribers]

  AxoGen Inc  (NASDAQ:AXGN)Q4 2018 Earnings Conference CallFeb. 26, 2019, 4:30 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Max Byerly]

  AxoGen, Inc Common Stock (NASDAQ:AXGN) – Investment analysts at Leerink Swann raised their FY2019 EPS estimates for shares of AxoGen, Inc Common Stock in a research report issued to clients and investors on Tuesday, August 21st. Leerink Swann analyst R. Newitter now forecasts that the medical equipment provider will earn ($0.39) per share for the year, up from their prior forecast of ($0.41). Leerink Swann currently has a “Outperform” rating and a $70.00 target price on the stock.

• [By Lee Jackson]

  Jefferies started coverage on this biotech/medical technology company with a Buy rating late last year. AxoGen Inc. (NASDAQ: AXGN) offers surgical solutions for peripheral nerve injuries. It provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane.

Top 10 Safest Stocks To Buy For 2019: Union Bankshares Corporation(UBSH)

Advisors' Opinion:

• [By Shane Hupp]

  Union Bankshares (NASDAQ:UBSH) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a report issued on Thursday.

• [By Motley Fool Staff]

  Union First Market Bankshares (NASDAQ:UBSH) Q2 2018 Earnings Conference CallJul. 18, 2018 9:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator 

• [By Max Byerly]

  Union Bankshares Corp (NASDAQ:UBSH) Director G William Beale sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, August 20th. The shares were sold at an average price of $41.56, for a total value of $41,560.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Top 10 Safest Stocks To Buy For 2019: Franklin Electric Co. Inc.(FELE)

Advisors' Opinion:

• [By Motley Fool Transcribers]

  Franklin Electric Co Inc  (NASDAQ:FELE)Q4 2018 Earnings Conference CallFeb. 19, 2019, 9:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Logan Wallace]

  Citadel Advisors LLC cut its holdings in shares of Franklin Electric Co. (NASDAQ:FELE) by 3.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 82,121 shares of the industrial products company’s stock after selling 3,340 shares during the quarter. Citadel Advisors LLC owned approximately 0.18% of Franklin Electric worth $3,704,000 as of its most recent SEC filing.

• [By Reuben Gregg Brewer]

  Industrial giant Franklin Electric Co., Inc. (NASDAQ:FELE) isn't exactly a household name, but it has managed to rack up some impressive dividend numbers. For example, it has increased its dividend each year for 26 consecutive years, and the annualized growth rate over the past decade is around 6%, roughly twice the historical rate of inflation growth. It's payout ratio, meanwhile, is a super-safe 25% or so. Before you jump at the stock, though, you should step back and consider some additional information.   

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on Franklin Electric (FELE)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Stephan Byrd]

  Equities researchers at DA Davidson started coverage on shares of Franklin Electric (NASDAQ:FELE) in a report issued on Monday, The Fly reports. The firm set a “neutral” rating on the industrial products company’s stock.

• [By Max Byerly]

  SG Americas Securities LLC cut its holdings in Franklin Electric Co. (NASDAQ:FELE) by 22.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,966 shares of the industrial products company’s stock after selling 2,042 shares during the quarter. SG Americas Securities LLC’s holdings in Franklin Electric were worth $299,000 at the end of the most recent quarter.

Top 10 Safest Stocks To Buy For 2019: Brookfield Renewable Powerr Fund(BEP)

Advisors' Opinion:

• [By Matthew DiLallo]

  Brookfield Renewable Partners' (NYSE:BEP) growth engine stalled out in the second quarter as its cash flow went in reverse due to lower rainfall levels in some areas, which impacted its ability to generate hydropower in those regions. However, while cash flow dipped in the quarter, the company's growth initiatives, when combined with the expansion opportunities it sees up ahead, should provide it with the power needed to generate a steadily growing cash flow stream in the years to come.

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Brookfield Renewable Partners (BEP)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Jason Hall]

  If you're looking for a solid dividend yield from an energy stock, two names that might be on your list are ExxonMobil (NYSE:XOM) and Brookfield Renewable Partners (NYSE:BEP). While one is the epitome of big oil and the other is more representative of the future of energy, both are known for their high dividend yields, strong cash flows that keep those payouts secure, and long track records of growing their dividend payments on a regular basis. 

Top 10 Safest Stocks To Buy For 2019: Greenlight Capital Re Ltd.(GLRE)

Advisors' Opinion:

• [By Ethan Ryder]

  Greenlight Capital Re (NASDAQ:GLRE) last issued its quarterly earnings results on Monday, April 30th. The financial services provider reported ($3.85) EPS for the quarter, beating the consensus estimate of ($4.43) by $0.58. Greenlight Capital Re had a negative return on equity of 23.81% and a negative net margin of 40.65%. The firm had revenue of $0.14 million during the quarter, compared to analysts’ expectations of $30.20 million. sell-side analysts forecast that Greenlight Capital Re, Ltd. will post -4.2 earnings per share for the current fiscal year.

• [By Max Byerly]

  Shares of Greenlight Capital Re, Ltd. (NASDAQ:GLRE) hit a new 52-week low on Wednesday . The company traded as low as $14.05 and last traded at $14.15, with a volume of 249308 shares changing hands. The stock had previously closed at $14.65.

• [By Logan Wallace]

  Greenlight Capital Re (NASDAQ:GLRE) was upgraded by analysts at ValuEngine from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Greenlight Capital Re (GLRE)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Safest Stocks To Buy For 2019: Oshkosh Corporation(OSK)

Advisors' Opinion:

• [By Stephan Byrd]

  Oshkosh Corp (NYSE:OSK) has been given a consensus rating of “Hold” by the seventeen analysts that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and nine have assigned a buy rating to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $89.87.

• [By Ethan Ryder]

  Penn Capital Management Co. Inc. increased its position in shares of Oshkosh Co. (NYSE:OSK) by 23.3% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 71,497 shares of the company’s stock after buying an additional 13,533 shares during the quarter. Penn Capital Management Co. Inc. owned about 0.10% of Oshkosh worth $5,693,000 as of its most recent SEC filing.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Oshkosh (OSK)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Oshkosh (OSK)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Safest Stocks To Buy For 2019: Ring Energy, Inc.(REI)

Advisors' Opinion:

• [By Logan Wallace]

  Ring Energy Inc (NYSEAMERICAN:REI) – Equities researchers at SunTrust Banks cut their Q3 2018 earnings per share (EPS) estimates for shares of Ring Energy in a report issued on Thursday, October 4th. SunTrust Banks analyst N. Dingmann now expects that the company will earn $0.11 per share for the quarter, down from their prior forecast of $0.12. SunTrust Banks also issued estimates for Ring Energy’s FY2019 earnings at $1.01 EPS and FY2020 earnings at $1.60 EPS.

• [By Stephan Byrd]

  RioCan Real Estate Investment Trust (TSE:REI) announced a monthly dividend on Friday, September 14th, Zacks reports. Investors of record on Friday, September 28th will be given a dividend of 0.12 per share on Friday, October 5th. This represents a $1.44 dividend on an annualized basis and a yield of 8.45%. The ex-dividend date of this dividend is Thursday, September 27th.

• [By Stephan Byrd]

  Vanguard Group Inc. lifted its position in Ring Energy Inc (NYSEAMERICAN:REI) by 2.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,422,953 shares of the company’s stock after acquiring an additional 72,507 shares during the quarter. Vanguard Group Inc. owned 5.65% of Ring Energy worth $33,922,000 as of its most recent SEC filing.

Top 10 Safest Stocks To Buy For 2019: GlobalSCAPE, Inc.(GSB)

Advisors' Opinion:

• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers Akorn, Inc. (NASDAQ: AKRX) fell 32.7 percent to $13.25 in pre-market trading after Fresenius terminated its merger deal with Akorn. Chicago Bridge & Iron Company N.V. (NYSE: CBI) fell 15.7 percent to $12.30 in pre-market trading. Subsea 7 confirmed a $7.00 per share proposal to acquire Mcdermott, pending termination of merger agreement with CB&I. Myomo, Inc. (NYSE: MYO) fell 9 percent to $3.65 in pre-market trading after rising 11.39 percent on Friday. Hasbro, Inc. (NASDAQ: HAS) fell 8 percent to $88.36 in pre-market trading after the company reported weaker-than-expected results for its first quarter on Monday. SunPower Corporation (NASDAQ: SPWR) fell 7.1 percent to $9.00 in pre-market trading. Endeavour Silver Corp. (NYSE: EXK) shares fell 5.9 percent to $2.88 in pre-market trading after declining 3.16 percent on Friday. Mattel, Inc. (NASDAQ: MAT) shares fell 5.5 percent to $12.25 in pre-market trading. Valeritas Holdings, Inc. (NASDAQ: VLRX) shares fell 5.1 percent to $2.96 in pre-market trading after rising 76.27 percent on Friday. GlobalSCAPE, Inc. (NYSE: GSB) fell 5.1 percent to $3.57 in pre-market trading. Fresenius Medical Care AG & Co. KGaA (NYSE: FMS) shares fell 4.1 percent to $49.93 in pre-market trading. Oasis Petroleum Inc. (NYSE: OAS) fell 4.1 percent to $9.75 in pre-market trading. SunTrust Robinson Humphrey downgraded Oasis Petroleum from Hold to Sell

Hot Biotech Stocks To Own Right Now

tags:BIIB,ARQL,AMGN,ALNY,

Corcept Therapeutics (NASDAQ:CORT) had its price target reduced by equities researchers at B. Riley from $30.00 to $22.00 in a research report issued to clients and investors on Monday, The Fly reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. B. Riley’s price objective suggests a potential upside of 76.42% from the stock’s previous close.

Several other research firms also recently weighed in on CORT. Stifel Nicolaus downgraded Corcept Therapeutics from a “buy” rating to a “hold” rating and set a $20.00 price target for the company. in a research report on Thursday, May 31st. BidaskClub raised Corcept Therapeutics from a “hold” rating to a “buy” rating in a research report on Saturday, May 19th. ValuEngine raised Corcept Therapeutics from a “hold” rating to a “buy” rating in a research report on Monday, May 14th. Finally, Zacks Investment Research raised Corcept Therapeutics from a “hold” rating to a “buy” rating and set a $19.00 price objective for the company in a research report on Friday, April 27th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $22.80.

Hot Biotech Stocks To Own Right Now: Biogen Idec Inc(BIIB)

Advisors' Opinion:

• [By Todd Campbell]

  Drugmakers' dustbins are filled with failed attempts to slow the progression of Alzheimer's disease, yet drug developers, including Biogen (NASDAQ:BIIB), remain undaunted in their pursuit of new treatments. Recently, Biogen reported data from a midstage trial that suggests it could be rewarded for its perseverance. In hundreds of patients, the company's BAN2401 successfully slowed disease progression as measured by the Alzheimer's Disease Composite Score (ADCOMS). Is this the breakthrough patients have been waiting for?

• [By Chris Lange]

  Short interest in Biogen Inc. (NASDAQ: BIIB) decreased to 4.29 million shares from the previous 4.73 million. The stock recently traded at $344.10, within a 52-week range of $249.17 to $370.57.

• [By Chris Lange]

  Short interest in Biogen Inc. (NASDAQ: BIIB) increased to 4.33 million shares from the previous 3.86 million. The stock recently traded at $306.68 within a 52-week range of $249.17 to $370.57.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Biogen (BIIB)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Biotech Stocks To Own Right Now: ArQule Inc.(ARQL)

Advisors' Opinion:

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on ArQule (ARQL)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Dan Caplinger]

  Thursday was another down day for the stock market, with new pressure coming from international moves on the macroeconomic front. The European Central Bank signaled that it was ready to provide more accommodative monetary policy, reversing a previous tightening stance and showing its concerns about the prospects for economic growth in the region. Yet favorable earnings reports continued lifting shares of certain individual companies. Rosetta Stone (NYSE:RST), ArQule (NASDAQ:ARQL), and Fly Leasing (NYSE:FLY) were among the top performers. Here's why they did so well.

• [By Joseph Griffin]

  ValuEngine upgraded shares of ArQule (NASDAQ:ARQL) from a buy rating to a strong-buy rating in a research report released on Tuesday.

  Several other equities analysts have also issued reports on ARQL. Zacks Investment Research upgraded ArQule from a hold rating to a buy rating and set a $2.50 price objective for the company in a research report on Tuesday, March 20th. BidaskClub upgraded ArQule from a buy rating to a strong-buy rating in a research report on Saturday, March 24th. B. Riley set a $4.00 price objective on ArQule and gave the company a buy rating in a research report on Monday, March 26th. Leerink Swann upgraded ArQule from a market perform rating to an outperform rating in a research report on Thursday, April 5th. Finally, Roth Capital boosted their price objective on ArQule from $5.00 to $6.00 and gave the company a buy rating in a research report on Tuesday, April 17th. One equities research analyst has rated the stock with a sell rating, five have assigned a buy rating and two have issued a strong buy rating to the stock. The company has a consensus rating of Buy and a consensus target price of $5.35.

Hot Biotech Stocks To Own Right Now: Amgen Inc.(AMGN)

Advisors' Opinion:

• [By ]

  For example, if you buy 100 shares of the Nasdaq 100 ETF (NYSE: QQQ), you're theoretically buying 11.9 shares of Apple (NASDAQ: AAPL)... 7.7 shares of Facebook (NASDAQ: FB)... 1.8 shares of Amgen (NASDAQ: AMGN)... 2.6 shares of Comcast (NASDAQ: CMCSA)... and even smaller amounts of about 95 different companies.

• [By Cory Renauer]

  Patient Amgen Inc. (NASDAQ:AMGN) shareholders have seen the stock quadruple in price over the past decade, plus they've enjoyed one of the fastest-growing dividends in biopharma. Now that the company's launched a new migraine headache drug, investors are wondering if the former highflier can put on another memorable performance.

• [By Jon C. Ogg]

  In September of 2016, Amgen Inc. (NASDAQ: AMGN) announced that the FDA had approved its Amjevita as a biosimilar to Humira for multiple inflammatory diseases that included RA and several other related inflammatory diseases.

• [By Keith Speights]

  Amgen (NASDAQ:AMGN) shareholders have to be pretty happy right now. The biotech stock is up nearly 14% so far in 2018, almost twice has much as the S&P 500 index. The company reported 17% year-over-year earnings growth in its second-quarter results announced in July.

Hot Biotech Stocks To Own Right Now: Alnylam Pharmaceuticals Inc.(ALNY)

Advisors' Opinion:

• [By Motley Fool Transcription]

  Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)Q4 2019 Earnings Conference CallFeb. 7, 2017, 4:30 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Max Byerly]

  Get a free copy of the Zacks research report on Alnylam Pharmaceuticals (ALNY)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Jim Crumly]

  Commercial success for Tegsedi is not a done deal even if it's approved worldwide; Alnylam Pharmaceuticals' (NASDAQ:ALNY) competing drug patisiran was approved by the FDA on Aug. 10. Alnylam's clinical testing showed cardiac benefits for patients whose cardiovascular systems have been affected by the disease, and Alnylam believes that will give patisiran an advantage over Tegsedi. But in the conference call, Akcea executives brushed off that concern and pointed to the advantage Tegsedi has in being an injection that can be delivered at home, versus patisiran, which is administered intravenously in a clinic. We shall see.

• [By Max Byerly]

  Alnylam Pharmaceuticals (NASDAQ:ALNY) last issued its quarterly earnings results on Thursday, May 3rd. The biopharmaceutical company reported ($1.41) EPS for the quarter, topping analysts’ consensus estimates of ($1.47) by $0.06. The business had revenue of $21.90 million during the quarter, compared to analysts’ expectations of $35.23 million. Alnylam Pharmaceuticals had a negative return on equity of 36.81% and a negative net margin of 565.20%. The business’s quarterly revenue was up 15.3% on a year-over-year basis. During the same quarter in the prior year, the business posted ($1.25) earnings per share. equities analysts anticipate that Alnylam Pharmaceuticals, Inc. will post -6.7 earnings per share for the current fiscal year.

• [By Brian Orelli]

  The delay in an FDA decision for Tegsedi puts it behind competitor Alnylam Pharmaceuticals (NASDAQ:ALNY), which expects to hear from the FDA by Aug. 11 for its hATTR drug patisiran. But Sarah Boyce, the president at Akcea Therapeutics, doesn't think a few months will really matter: "We don't really feel that's going to have any impact and the drugs will be close enough together from a launch perspective. So not really [going] to make any adjustments, and we're very well prepared to be ready to launch following approval."

• [By Jim Crumly]

  You would think that when a drug company that's been working for 16 years to develop drugs using a novel therapeutic approach wins its first-ever approval from the U.S. Food and Drug Administration (FDA), confetti would fall from the ceiling and its investors would be celebrating a huge stock gain the next day. That didn't happen this week for shareholders of Alnylam Pharmaceuticals (NASDAQ:ALNY), with shares dropping 6.6% the day after the announcement, and there were two main reasons for that.

5 Social Security Tips for 2019 -- and Beyond

Social Security helps millions of seniors pay the bills and enjoy retirement to the fullest. If you expect to count on those benefits, you'll need to be strategic in claiming them. Here are a few key things you ought to know that will help you make the most of Social Security, whether you're filing this year or in the future.

1. Commit your full retirement age to memory

This is the age at which you're entitled to collect your full monthly benefit without a reduction. Although benefits are based on your earnings history -- specifically, your 35 highest years of earnings -- the age at which you file for them could cause that number to go up or down. If you file ahead of full retirement age, your benefits will be reduced for each month you claim them early, which is why it often pays to sit tight and wait until you can collect your benefits in full.

IMAGE SOURCE: GETTY IMAGES.

Here's what full retirement age looks like, depending on your year of birth:

Year of Birth

Full Retirement Age

1943-1954	66
1955	66 and 2 months
1956	66 and 4 months
1957	66 and 6 months
1958	66 and 8 months
1959	66 and 10 months
1960	67

DATA SOURCE: SOCIAL SECURITY ADMINISTRATION.

If you were born in 1953, you'll hit full retirement age at some point this year. But if you were born anytime after that, waiting to file for Social Security will help you avoid a reduction in your benefits.

2. Know what the average benefit looks like

Though your Social Security benefits will be based on your specific earnings record, it might help you to know that the average recipient this year collects $1,461 a month, or $17,532 a year. That's not a whole lot of income by itself, and if you file ahead of full retirement age, you'll reduce that sum to a smaller amount. Keep in mind that Social Security isn't designed to sustain seniors in the absence of other income, so if you're low on independent savings, you definitely can't afford a reduction. If you want to know what your specific benefits will look like, you can create an account on the Social Security Administration's website and get an estimate.

3. Report mistakes on your earnings record

The Social Security Administration keeps track of your earnings for the purpose of calculating your retirement benefits, so if your personal record contains an error that works against you, your benefits could take a hit. Imagine, for example, that you earned $52,000 in 2017, only the SSA doesn't have any income on file for you that year. It's an odd thing to have happen, but it is possible. If you don't correct that error, you could lose out on income in retirement. Therefore, make a point of checking your earnings statements every year. You can access them by creating an account on the Social Security Administration's website if you don't receive them in the mail (which you won't if you're under 60).

4. Be aware of the earnings test limits

If you're working and collecting Social Security simultaneously but haven't yet reached full retirement age, you're subject to what's known as the earnings test. This year, you can earn up to $17,640 before having benefits withheld, but once your income surpasses that point, you'll lose $1 in Social Security for every $2 in earnings. If you'll be reaching full retirement age at any point this year, you can earn up to $46,920 without having benefits withheld. From there, you'll lose $1 in Social Security for every $3 in earnings.

Keep in mind that the benefits you have withheld under the earnings test aren't lost permanently; they'll be added back into your monthly payments once you reach full retirement age. However, the reduction you face in your monthly benefits by filing before full retirement age will be permanent unless you manage to undo your application within a year and repay every cent you collected to the Social Security Administration.

5. Know that delaying benefits pays off

Waiting until full retirement age to claim your benefits will help you avoid a reduction in Social Security income. An even better bet, however, might be to delay benefits past full retirement age. For each year that you do up until age 70, you'll boost your benefits by 8%. That increase will then remain in effect for the rest of your life, so if you're entering retirement without much in personal savings, scoring a larger monthly benefit is a good way to compensate.

The smarter you are about Social Security, the more you stand to gain from it. Keep these tips in mind, whether you're filing for benefits this year or are planning to do so well into the future.

Advisory Resource Group Invests $298,000 in Invesco Dynamic Large Cap Value ETF (PWV) Stock

Advisory Resource Group purchased a new position in Invesco Dynamic Large Cap Value ETF (NYSEARCA:PWV) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 9,120 shares of the company’s stock, valued at approximately $298,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Capital Investment Advisory Services LLC bought a new stake in Invesco Dynamic Large Cap Value ETF in the fourth quarter worth $25,000. IFP Advisors Inc lifted its position in shares of Invesco Dynamic Large Cap Value ETF by 52.8% during the fourth quarter. IFP Advisors Inc now owns 4,428 shares of the company’s stock worth $143,000 after purchasing an additional 1,530 shares during the last quarter. LexAurum Advisors LLC bought a new stake in shares of Invesco Dynamic Large Cap Value ETF during the third quarter worth $207,000. JPMorgan Chase & Co. bought a new stake in shares of Invesco Dynamic Large Cap Value ETF during the third quarter worth $238,000. Finally, Rehmann Capital Advisory Group lifted its position in shares of Invesco Dynamic Large Cap Value ETF by 3,638.0% during the third quarter. Rehmann Capital Advisory Group now owns 6,990 shares of the company’s stock worth $187,000 after purchasing an additional 6,803 shares during the last quarter.

Get Invesco Dynamic Large Cap Value ETF alerts:

NYSEARCA:PWV opened at $35.35 on Friday. Invesco Dynamic Large Cap Value ETF has a twelve month low of $30.64 and a twelve month high of $38.73.

TRADEMARK VIOLATION NOTICE: “Advisory Resource Group Invests $298,000 in Invesco Dynamic Large Cap Value ETF (PWV) Stock” was originally reported by Ticker Report and is owned by of Ticker Report. If you are reading this story on another website, it was illegally copied and republished in violation of US and international trademark & copyright legislation. The correct version of this story can be read at https://www.tickerreport.com/banking-finance/4205317/advisory-resource-group-invests-298000-in-invesco-dynamic-large-cap-value-etf-pwv-stock.html.

Invesco Dynamic Large Cap Value ETF Company Profile

PowerShares Dynamic Large Cap Value Portfolio (the Fund) seeks investment results that correspond generally to the price and yield of the Dynamic Large Cap Value Intellidex Index (the Index). The Index is designed to provide capital appreciation, while maintaining consistent stylistically accurate exposure.

Featured Story: Swap

Want to see what other hedge funds are holding PWV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Dynamic Large Cap Value ETF (NYSEARCA:PWV).

Top 5 Medical Stocks To Buy For 2019

tags:AME,MNK,STWD,MVF,CLLS,

Media stories about Genomic Health (NASDAQ:GHDX) have trended somewhat negative recently, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Genomic Health earned a news sentiment score of -0.05 on Accern’s scale. Accern also gave news headlines about the medical research company an impact score of 45.5633483520665 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

These are some of the news headlines that may have effected Accern Sentiment’s scoring:

Top 5 Medical Stocks To Buy For 2019: AMTEK, Inc.(AME)

Advisors' Opinion:

• [By Joseph Griffin]

  AMETEK (NYSE:AME) had its target price upped by BMO Capital Markets from $92.00 to $93.00 in a report issued on Wednesday morning. BMO Capital Markets currently has an outperform rating on the technology company’s stock.

• [By Shane Hupp]

  Mountain Pacific Investment Advisers Inc. ID trimmed its stake in shares of AMETEK, Inc. (NYSE:AME) by 1.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 533,274 shares of the technology company’s stock after selling 5,917 shares during the quarter. AMETEK accounts for 4.2% of Mountain Pacific Investment Advisers Inc. ID’s portfolio, making the stock its 3rd largest holding. Mountain Pacific Investment Advisers Inc. ID’s holdings in AMETEK were worth $40,513,000 as of its most recent SEC filing.

• [By Max Byerly]

  Legal & General Group Plc lowered its stake in shares of AMETEK, Inc. (NYSE:AME) by 6.4% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,080,233 shares of the technology company’s stock after selling 73,951 shares during the quarter. Legal & General Group Plc owned about 0.47% of AMETEK worth $82,065,000 at the end of the most recent quarter.

• [By Max Byerly]

  Here are some of the media stories that may have impacted Accern Sentiment’s rankings:

  Get AMETEK alerts: Haydon Kerk Motion Solutions Releases 2018 Linear Motion Catalog and Design Guide (news.thomasnet.com) Global Electric Motor Market 2018 – Ametek, Inc., Bosch Group, Emerson Electric Co., Hitachi, Ltd. (journalcommunication.com) Grass isn’t always greener with these two names: AMETEK, Inc. (AME), CYS Investments, Inc. (CYS) (fintelegraph.com) Global Motor Vehicle Sensors Market 2018 – Agilent Technologies, Ametek Inc., Analog Devices Inc., Ashcroft … (globaltopkeyplayers.com) Why these Stocks Could Be Off to the Races? AMETEK, Inc. (AME) and Simon Property Group, Inc. (SPG) (nmsunews.com)

  Shares of AME traded down $0.49 on Thursday, reaching $74.84. 887,300 shares of the stock traded hands, compared to its average volume of 1,284,629. The stock has a market cap of $17.51 billion, a PE ratio of 28.67, a P/E/G ratio of 2.42 and a beta of 1.26. The company has a current ratio of 1.69, a quick ratio of 1.18 and a debt-to-equity ratio of 0.45. AMETEK has a 12 month low of $59.56 and a 12 month high of $79.32.

• [By Logan Wallace]

  These are some of the news articles that may have impacted Accern Sentiment’s scoring:

  Get AMETEK alerts: Ac Power Source Supply Market 2018 Global Share- AMETEK Programmable Power, Pacific Power Source and … (theexpertconsulting.com) The Whispers about AMETEK, Inc. (AME) and Omeros Corporation (OMER) (nmsunews.com) Global Neutron Generators Market Analysis 2018 Del Mar Photonics, VNIIA, AMETEK ORTEC, Adelphi Technology … (theexpertconsulting.com) AMETEK, Inc. (AME): Most Popular stock: (stockquote.review) Ametek granted partial judgment in alleged ground contamination cased filed by mobile home parks’ owners (norcalrecord.com)

  Several research firms have recently commented on AME. Morgan Stanley lifted their price target on shares of AMETEK from $76.00 to $79.00 and gave the company an “equal weight” rating in a research report on Thursday, May 3rd. BMO Capital Markets lifted their price target on shares of AMETEK from $90.00 to $92.00 and gave the company an “outperform” rating in a research report on Thursday, May 3rd. Zacks Investment Research lowered shares of AMETEK from a “buy” rating to a “hold” rating in a research report on Thursday, April 12th. DA Davidson began coverage on shares of AMETEK in a research report on Thursday, April 12th. They set a “buy” rating and a $85.00 price target on the stock. Finally, ValuEngine raised shares of AMETEK from a “hold” rating to a “buy” rating in a research report on Thursday, March 1st. Three investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $82.00.

• [By Ethan Ryder]

  Rhumbline Advisers grew its holdings in shares of AMETEK, Inc. (NYSE:AME) by 3.0% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 450,212 shares of the technology company’s stock after purchasing an additional 13,189 shares during the quarter. Rhumbline Advisers’ holdings in AMETEK were worth $32,487,000 at the end of the most recent reporting period.

Top 5 Medical Stocks To Buy For 2019: Mallinckrodt plc(MNK)

Advisors' Opinion:

• [By Joseph Griffin]

  An issue of Mallinckrodt PLC (NYSE:MNK) debt rose 0.6% against its face value during trading on Monday. The debt issue has a 5.75% coupon and will mature on August 1, 2022. The bonds in the issue are now trading at $94.50 and were trading at $91.75 last week. Price moves in a company’s debt in credit markets sometimes anticipate parallel moves in its stock price.

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Mallinckrodt (MNK)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Dan Caplinger]

  Wall Street moved lower on Thursday, with the Dow Jones Industrial Average suffering a 201-point decline. Stocks took their cues from the bond market, where bond prices dropped sharply in response to extremely strong U.S. economic data. For years, the economic expansion has given bond investors a Goldilocks scenario, in which growth was solid but not so sharp as to cause negative side effects, such as inflation. Now, stronger signals could force the Federal Reserve to raise interest rates more aggressively than previously thought, and that could hurt the markets. Several individual companies also suffered from bad news that sent their shares lower. Mallinckrodt (NYSE:MNK), International Speedway (NASDAQ:ISCA), and LGI Homes (NASDAQ:LGIH) were among the worst performers on the day. Here's why they did so poorly.

Top 5 Medical Stocks To Buy For 2019: STARWOOD PROPERTY TRUST, INC.(STWD)

Advisors' Opinion:

• [By Logan Wallace]

  Dynamic Technology Lab Private Ltd bought a new stake in Starwood Property Trust, Inc. (NYSE:STWD) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 25,758 shares of the real estate investment trust’s stock, valued at approximately $560,000.

• [By Max Byerly]

  JPMorgan Chase & Co. initiated coverage on shares of Starwood Property Trust (NYSE:STWD) in a report issued on Friday, Marketbeat.com reports. The brokerage set an “overweight” rating and a $23.00 price target on the real estate investment trust’s stock. JPMorgan Chase & Co.’s target price would suggest a potential upside of 5.12% from the company’s current price.

• [By Joseph Griffin]

  Strs Ohio acquired a new stake in shares of Starwood Property Trust, Inc. (NYSE:STWD) in the second quarter, HoldingsChannel.com reports. The firm acquired 28,456 shares of the real estate investment trust’s stock, valued at approximately $617,000.

• [By Motley Fool Transcribers]

  Starwood Property Trust Inc  (NYSE:STWD)Q4 2018 Earnings Conference CallFeb. 28, 2019, 10:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

Top 5 Medical Stocks To Buy For 2019: MuniVest Fund, Inc.(MVF)

Advisors' Opinion:

• [By Max Byerly]

  BlackRock MuniVest Fund Inc. (NYSEAMERICAN:MVF) declared a monthly dividend on Thursday, September 6th, Wall Street Journal reports. Stockholders of record on Friday, September 14th will be paid a dividend of 0.041 per share by the investment management company on Monday, October 1st. This represents a $0.49 annualized dividend and a dividend yield of 5.57%. The ex-dividend date of this dividend is Thursday, September 13th.

Top 5 Medical Stocks To Buy For 2019: Cellectis S.A.(CLLS)

Advisors' Opinion:

• [By Stephan Byrd]

  Shares of Cellectis SA (NASDAQ:CLLS) have earned an average recommendation of “Hold” from the nine research firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $42.00.

• [By Ethan Ryder]

  Media headlines about Cellectis (NASDAQ:CLLS) have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cellectis earned a media sentiment score of 0.19 on Accern’s scale. Accern also assigned media stories about the biotechnology company an impact score of 47.0875412676142 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.